PT  - JOURNAL ARTICLE
AU  - Vinall, Maria
ED  - Alfonso, Fernando
TI  - RIBS IV: EES Superior to Paclitaxel-Eluting Balloon for Treating DES Restenosis
DP  - 2014 Nov 01
TA  - MD Conference Express
PG  - 12--13
VI  - 14
IP  - 30
4099  - http://mdc.sagepub.com/content/14/30/12.short
4100  - http://mdc.sagepub.com/content/14/30/12.full
AB  - Treatment of drug-eluting stent in-stent restenosis (DES-ISR) is challenging. Results from the Restenosis Intra-Stent of Drug-Eluting Stents: Paclitaxel-Eluting Balloon vs Everolimus-Eluting Stent trial [RIBS IV; NCT01239940] indicate that DES provide superior late angiographic clinical outcomes compared with drug-eluting balloons.